skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Including "chemotherapy"   Just search Overweight drug therapy

Results 1 - 20 of 94,479  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Long term pharmacotherapy for obesity and overweight: updated meta-analysis
Long term pharmacotherapy for obesity and overweight: updated meta-analysis
Material Type:
Article 		Add to My Research

Long term pharmacotherapy for obesity and overweight: updated meta-analysis

BMJ, 2007-12, Vol.335 (7631), p.1194-1199 [Peer Reviewed Journal]

BMJ Publishing Group Ltd 2007 ;Copyright 2007 BMJ Publishing Group Ltd. ;Copyright: 2007 (c) BMJ Publishing Group Ltd 2007 ;BMJ Publishing Group Ltd 2007 2007 BMJ Publishing Group Ltd ;ISSN: 0959-8138 ;EISSN: 1468-5833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.39385.413113.25 ;PMID: 18006966

Full text available

Citations Cited by
2
Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients
Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients
Material Type:
Article 		Add to My Research

Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients

Investigational new drugs, 2017-08, Vol.35 (4), p.436-441 [Peer Reviewed Journal]

Springer Science+Business Media New York 2017 ;Investigational New Drugs is a copyright of Springer, 2017. ;ISSN: 0167-6997 ;EISSN: 1573-0646 ;DOI: 10.1007/s10637-017-0464-x ;PMID: 28396974

Full text available

Citations Cited by
3
Prediction of Vancomycin Levels Using Cystatin C in Overweight and Obese Patients: a Retrospective Cohort Study of Hospitalized Patients
Prediction of Vancomycin Levels Using Cystatin C in Overweight and Obese Patients: a Retrospective Cohort Study of Hospitalized Patients
Material Type:
Article 		Add to My Research

Prediction of Vancomycin Levels Using Cystatin C in Overweight and Obese Patients: a Retrospective Cohort Study of Hospitalized Patients

Antimicrobial agents and chemotherapy, 2020-12, Vol.65 (1) [Peer Reviewed Journal]

Copyright © 2020 American Society for Microbiology. ;Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/AAC.01487-20 ;PMID: 33106257

Full text available

Citations Cited by
4
Pharmacological Approaches in the Treatment and Maintenance of Weight Loss
Pharmacological Approaches in the Treatment and Maintenance of Weight Loss
Material Type:
Article 		Add to My Research

Pharmacological Approaches in the Treatment and Maintenance of Weight Loss

Diabetes care, 2016-08, Vol.39 Suppl 2 (Supplement_2), p.S260-S267 [Peer Reviewed Journal]

2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dcS15-3016 ;PMID: 27440841

Full text available

Citations Cited by
5
Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen-Directed Radioligand Therapy
Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen-Directed Radioligand Therapy
Material Type:
Article 		Add to My Research

Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen-Directed Radioligand Therapy

Journal of Nuclear Medicine, 2023-08, Vol.64 (8), p.1272-1278 [Peer Reviewed Journal]

2023 by the Society of Nuclear Medicine and Molecular Imaging. ;Copyright Society of Nuclear Medicine Aug 1, 2023 ;ISSN: 0161-5505 ;EISSN: 1535-5667 ;EISSN: 2159-662X ;DOI: 10.2967/jnumed.122.265379 ;PMID: 37290794

Full text available

Citations Cited by
6
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha (Withania somnifera) in Aging, Overweight Males
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha (Withania somnifera) in Aging, Overweight Males
Material Type:
Article 		Add to My Research

A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha (Withania somnifera) in Aging, Overweight Males

American journal of men's health, 2019-03, Vol.13 (2), p.1557988319835985-1557988319835985 [Peer Reviewed Journal]

The Author(s) 2019 ;The Author(s) 2019. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://www.creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 2019 SAGE Publications Inc unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses ;ISSN: 1557-9883 ;EISSN: 1557-9891 ;DOI: 10.1177/1557988319835985 ;PMID: 30854916

Full text available

Citations Cited by
7
Effect of metformin as an adjuvant therapy to letrozole on estradiol and other biomarkers involved in the pathogenesis of breast cancer in overweight and obese postmenopausal women: a pilot study
Effect of metformin as an adjuvant therapy to letrozole on estradiol and other biomarkers involved in the pathogenesis of breast cancer in overweight and obese postmenopausal women: a pilot study
Material Type:
Article 		Add to My Research

Effect of metformin as an adjuvant therapy to letrozole on estradiol and other biomarkers involved in the pathogenesis of breast cancer in overweight and obese postmenopausal women: a pilot study

European journal of clinical pharmacology, 2023-02, Vol.79 (2), p.299-309 [Peer Reviewed Journal]

The Author(s) 2022 ;2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-022-03444-6 ;PMID: 36562831

Full text available

Citations Cited by
8
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
Material Type:
Article 		Add to My Research

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

Nature medicine, 2022-10, Vol.28 (10), p.2083-2091 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-022-02026-4 ;PMID: 36216945

Full text available

Citations Cited by
9
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
Material Type:
Article 		Add to My Research

Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials

The Lancet (British edition), 2022-01, Vol.399 (10321), p.259-269 [Peer Reviewed Journal]

Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01640-8 ;PMID: 34895470

Full text available

Citations Cited by
10
Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
Material Type:
Article 		Add to My Research

Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes

Diabetes care, 2013-12, Vol.36 (12), p.4022-4029 [Peer Reviewed Journal]

2015 INIST-CNRS ;COPYRIGHT 2013 American Diabetes Association ;Copyright American Diabetes Association Dec 2013 ;2013 by the American Diabetes Association. 2013 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc13-0234 ;PMID: 24144653 ;CODEN: DICAD2

Full text available

Citations Cited by
11
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
Material Type:
Article 		Add to My Research

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial

Diabetes care, 2020-05, Vol.43 (5), p.1085-1093 [Peer Reviewed Journal]

2020 by the American Diabetes Association. ;Copyright American Diabetes Association May 1, 2020 ;2020 by the American Diabetes Association 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc19-1745 ;PMID: 32139381

Full text available

Citations Cited by
12
Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults
Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults
Material Type:
Article 		Add to My Research

Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults

Gut, 2015-11, Vol.64 (11), p.1744-1754 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2014-307913 ;PMID: 25500202 ;CODEN: GUTTAK

Full text available

Citations Cited by
13
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
Material Type:
Article 		Add to My Research

Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study

Diabetes care, 2021-06, Vol.44 (6), p.1433-1442 [Peer Reviewed Journal]

2021 by the American Diabetes Association. ;Copyright American Diabetes Association Jun 1, 2021 ;2021 by the American Diabetes Association 2021 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-2151 ;PMID: 34016612

Full text available

Citations Cited by
14
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
Material Type:
Article 		Add to My Research

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

The New England journal of medicine, 2018-09, Vol.379 (12), p.1107-1117 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1808721 ;PMID: 30145941

Full text available

Citations Cited by
15
Voriconazole Serum Concentrations in Obese and Overweight Immunocompromised Patients: A Retrospective Review
Voriconazole Serum Concentrations in Obese and Overweight Immunocompromised Patients: A Retrospective Review
Material Type:
Article 		Add to My Research

Voriconazole Serum Concentrations in Obese and Overweight Immunocompromised Patients: A Retrospective Review

Pharmacotherapy, 2013-01, Vol.33 (1), p.22-30 [Peer Reviewed Journal]

2013 Pharmacotherapy Publications, Inc. ;2014 INIST-CNRS ;ISSN: 0277-0008 ;EISSN: 1875-9114 ;DOI: 10.1002/phar.1156 ;PMID: 23307541 ;CODEN: PHPYDQ

Full text available

Citations Cited by
16
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
Material Type:
Article 		Add to My Research

Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design

The American heart journal, 2020-11, Vol.229, p.61-69 [Peer Reviewed Journal]

2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved. ;2020. The Author(s) ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2020.07.008 ;PMID: 32916609

Full text available

Citations Cited by
17
Benefits of weight loss of 10% or more in patients with overweight or obesity: A review
Benefits of weight loss of 10% or more in patients with overweight or obesity: A review
Material Type:
Article 		Add to My Research

Benefits of weight loss of 10% or more in patients with overweight or obesity: A review

Obesity (Silver Spring, Md.), 2022-04, Vol.30 (4), p.802-840 [Peer Reviewed Journal]

2022 The Obesity Society ;2022 The Obesity Society. ;Copyright Blackwell Publishing Ltd. Apr 2022 ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1002/oby.23371 ;PMID: 35333446

Full text available

Citations Cited by
18
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Material Type:
Article 		Add to My Research

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet (British edition), 2010-08, Vol.376 (9741), p.595-605 [Peer Reviewed Journal]

Elsevier Ltd ;2010 Elsevier Ltd ;2015 INIST-CNRS ;Copyright 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 21-Aug 27, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)60888-4 ;PMID: 20673995 ;CODEN: LANCAO

Full text available

Citations Cited by
19
Effect of the Look AHEAD Study Intervention on Medication Use and Related Cost to Treat Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
Effect of the Look AHEAD Study Intervention on Medication Use and Related Cost to Treat Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
Material Type:
Article 		Add to My Research

Effect of the Look AHEAD Study Intervention on Medication Use and Related Cost to Treat Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes

Diabetes care, 2010-06, Vol.33 (6), p.1153-1158 [Peer Reviewed Journal]

2015 INIST-CNRS ;COPYRIGHT 2010 American Diabetes Association ;Copyright American Diabetes Association Jun 2010 ;2010 by the American Diabetes Association. 2010 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc09-2090 ;PMID: 20332353 ;CODEN: DICAD2

Full text available

Citations Cited by
20
Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation
Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation
Material Type:
Article 		Add to My Research

Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation

Diabetes (New York, N.Y.), 2016-08, Vol.65 (8), p.2282-2294 [Peer Reviewed Journal]

2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Aug 1, 2016 ;ISSN: 0012-1797 ;EISSN: 1939-327X ;DOI: 10.2337/db16-0153 ;PMID: 27207552 ;CODEN: DIAEAZ

Full text available

Citations Cited by

Results 1 - 20 of 94,479  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (82,290)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1964  (41)
  2. 1964 To 1978  (140)
  3. 1979 To 1993  (628)
  4. 1994 To 2009  (18,493)
  5. After 2009  (75,428)
  6. More options open sub menu

Subject 

  1. Science & Technology  (69,784)
  2. Life Sciences & Biomedicine  (65,412)
  3. Humans  (47,425)
  4. Female  (28,666)
  5. Male  (24,715)
  6. Obesity  (22,226)
  7. Risk Factors  (19,422)
  8. Middle Aged  (19,021)
  9. Diabetes  (18,123)
  10. Adult  (17,573)
  11. Body Mass Index  (16,276)
  12. Aged  (12,932)
  13. Patients  (12,105)
  14. Health Aspects  (11,147)
  15. Endocrinology & Metabolism  (10,707)
  16. Medicine  (9,696)
  17. Care And Treatment  (9,204)
  18. Hypertension  (8,822)
  19. Review  (8,623)
  20. Metabolism  (8,574)
  21. More options open sub menu

Language 

  1. English  (94,051)
  2. Japanese  (8,533)
  3. Portuguese  (486)
  4. Spanish  (226)
  5. French  (166)
  6. German  (137)
  7. Turkish  (127)
  8. Polish  (109)
  9. Russian  (82)
  10. Norwegian  (77)
  11. Italian  (41)
  12. Chinese  (40)
  13. Croatian  (18)
  14. Dutch  (13)
  15. Czech  (11)
  16. Korean  (11)
  17. Ukrainian  (11)
  18. Afrikaans  (10)
  19. Swedish  (9)
  20. Persian  (7)
  21. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait